Filing Flows › Bodhi Tree Biotechnology (BDTB) › Q3 FY26
Bodhi Tree Biotechnology (BDTB) Q3 FY26 earnings results (third quarter fiscal 2026)
10-Q filed Aug 14, 2026
Bodhi Tree Biotechnology (BDTB) reported revenue of $10K for the third quarter fiscal 2026 (Q3 FY26) and -33% from the quarter before. Operating margin was -231.9%, net loss $23K (231.9% of revenue).
Bodhi Tree Biotechnology, Q3 FY26: revenue $10K, operating margin -232.0%, net loss $23K, operating cash flow −$19K. The chart follows the revenue to costs, profit and cash.
| Q3 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10K | -33% | — |
| Operating profit | −$23K | — | — |
| Net earnings | −$23K | — | — |
| Operating cash flow | −$19K | — | — |
What changed
Revenue was $10K in Q3 FY26, down 33% from the previous quarter.
Operating costs exceeded revenue by $23K, an operating margin of -232.0%. The quarter ended with a net loss of $23K, narrower than the previous quarter's $29K loss.
Operating cash flow was −$19K. Working capital and other items added $4K.
Questions
What was Bodhi Tree Biotechnology's revenue in the third quarter fiscal 2026?
Bodhi Tree Biotechnology (BDTB) reported revenue of $10K for the third quarter fiscal 2026 (Q3 FY26) and -33% from the quarter before.
Was Bodhi Tree Biotechnology profitable in the third quarter fiscal 2026?
Operating loss was $23K (-231.9% of revenue) and net loss $23K.